ANKRD11P1

Across TCGA pan-cancer cohorts, ANKRD11P1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated ANKRD11P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ANKRD11P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD11P1 expression acts as an unfavorable survival marker, although some lineages such as READ and BRCA show a favorable association.

ACC, UVM, and DLBC are the cancer types where ANKRD11P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.357	0.694	.001	75	view →
UVM	OS	Tertile	III,IV	0.477	0.845	.008	27	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
ESCA	DFS	Tertile	IV	0.216	0.542	.021	24	view →
READ	OS	Tertile	III,IV	1.000	0.309	.006	24	view →
THCA	OS	Tertile	IV	0.831	1.000	.001	21	view →
KIRC	DFS	Quartile	III,IV	0.449	0.760	<.001	17	view →
UCEC	DFS	Tertile	All	0.416	0.714	.007	14	view →
BRCA	DFS	Tertile	III,IV	0.934	0.856	.017	12	view →
STAD	OS	Tertile	II,III,IV	0.565	0.758	.040	12	view →
CESC	OS	Tertile	All	0.875	0.761	.031	12	view →
BLCA	DFS	Tertile	IV	0.237	0.510	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

ANKRD11P1–ACC (OS)

Open the ACC breakdown →